
Sign up to save your podcasts
Or


This week a nice case control study out of Mayo challenged my own bias against MTX in GCA. This prompted a deep dive into the literature, including 3 RCTs and meta analysis. At the end of the day, I'm more (almost) fully convinced that MTX offers a (mediocre) benefit.
Follow me on twitter (@ebrheum) to share your thoughts and find all of the PDFs at my Box on ebrheum.com.
By Michael Putman4.9
113113 ratings
This week a nice case control study out of Mayo challenged my own bias against MTX in GCA. This prompted a deep dive into the literature, including 3 RCTs and meta analysis. At the end of the day, I'm more (almost) fully convinced that MTX offers a (mediocre) benefit.
Follow me on twitter (@ebrheum) to share your thoughts and find all of the PDFs at my Box on ebrheum.com.

320 Listeners

496 Listeners

885 Listeners

129 Listeners

1,149 Listeners

120 Listeners

194 Listeners

172 Listeners

68 Listeners

247 Listeners

4 Listeners

181 Listeners

11 Listeners

18 Listeners

7 Listeners